Homologous Total
TCGA-2Y-A9H1 11 2 3 aa 7 aa TCGA-4R-AA8I 47 2 3 aa 6 aa TCGA-BC-A10W 8 0 3 aa 7 aa TCGA-CC-5258 8 1 3 aa 7 aa TCGA-CC-5264 10 2 3 aa 6 aa TCGA-CC-A5UD 12 3 3 aa 6 aa TCGA-CC-A8HV 12 2 3 aa 6 aa TCGA-DD-A116 9 3 3 aa 7 aa TCGA-DD-AACC 14 2 3 aa 6 aa TCGA-DD-AACD 12 1 2 aa 7 aa TCGA-DD-AACL 11 3 3 aa 7 aa TCGA-EP-A2KC 6 2 3 aa 6 aa TCGA-G3-A7M9 11 0 3 aa 6 aa TCGA-GJ-A6C0 8 1 3 aa 7 aa TCGA-KR-A7K0 8 1 3 aa 6 aa TCGA-XR-A8TF 6 1 3 aa 6 aa TCGA-ZP-A9D4 7 1 4 aa 7 aa Table S3 . Alignment of each predicted mutated neoantigen and the homologous pathogen derived antigen from iedb.org. Green letters, indicate identical residues between the two sequences; Red letters, indicate different residues between the two sequences. Peptide  p1  p2  p3  p4  p5  p6  p7  p8 p9
HCC SAMPLE
*samples with neoantigens with homology also to cellular self antigens. Table S4 . Alignment of each predicted mutated neoantigen and the homologous cellular self antigen from iedb.org. Green letters, indicate identical residues between the two sequences; Red letters, indicate different residues between the two sequences.
*samples with neoantigens with homology also to cellular pathogen-derived antigens. Figure S7 . GZMA, neoantigens and survival.
